Jonathan Bricker, PhD, and Fred Hutch’s Health and Behavioral Innovations in Technology (HABIT) research group developed an AI-powered chatbot app called QuitBot to help more people successfully quit ...
Fred Hutch researchers launch free online tool to assess colorectal cancer risk Researchers led by Ulrike “Riki” Peters, PhD, MPH, holder of the 40th Anniversary Endowed Chair, and Li Hsu, PhD, ...
Medical Director, Radiation Oncology, Fred Hutch Professor, Vice Chair of Faculty Affairs, Clinical Research Director, Division of Radiation Oncology, University of Washington School of Medicine ...
The good news? Enrollment in new cancer therapy clinical trials has returned to normal, at least within one large trial network, a year after the pandemic began. The bad news? Normal trial enrollment ...
Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...
If there is one thing most of us have learned about the coronavirus itself, we know it is covered with spikes. In news broadcasts about the COVID-19 crisis, that gray Styrofoam ball dotted with red ...
After being diagnosed and treated for breast cancer three separate times, Liza Bernstein, 51, of Los Angeles has her life, her family and friends, her hopes and dreams, her art, and a renewed sense of ...
Here’s an equation to solve: What do you get when you add research jargon with statistics and multiply by the human brain’s tricks of perception? The answer, for many of us, is confusion. Statistics ...
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the ...
It takes a persistent scientist to stop a persistent virus. A decade ago, Fred Hutchinson Cancer Research Center virologist Dr. Keith Jerome began exploring the idea that lifelong infections with ...
The Cancer Screening Research Network's (CSRN) primary focus is to reduce cancer-related illnesses and deaths by evaluating new and complex technologies that screen for cancer. The CSRN is a ...
Physician, Fred Hutch Associate Professor, Translational Science and Therapeutics Division, Fred Hutch Associate Professor, Division of Hematology and Oncology, University of Washington School of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results